When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

Scientists have designed a slimmed-down CRISPR protein, enEbCas12a, that still packs a punch in precision editing. Its small size means it can hitch a ride in a harmless virus, delivering edits ...

The first in-human trial of a CRISPR Cas system delivered by adeno-associated virus 9 gene therapy to treat HIV was able to target only the intended DNA and cleared the blood within 6 months.

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather than permanently altering the genome.

Researchers announced three distinct CRISPR developments: a diagnostic test that distinguishes multiple viruses by reaction speed, early trial results for an autoimmune cell therapy, and laboratory ...

Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver ...

As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single ...

A new way to eradicate HIV from the body could one day be turned into a cure for infection by this virus, although it hasn’t yet been shown to work in people. The strategy uses a relatively recent ...

As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single test are becoming ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...